Colonics
About Me
Recent Posts
- Surface analysis exposes counterfeit medicines
- Cancer-Like Response Triggered From Embryonic Stem Cells By Forsyth Scientists
- Global Health Group to assist Namibia in developing strategic malaria control plan
- Tracking down the cause of Mad Cow disease - first synthetic prion protein with an anchor
- Collaboration To Identify And Monitor Autologous Adult Stem Cells For Use In Stem Cell Therapy Using Protein Biomarkers
Menu
Calendar
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | 31 | ||
Friends
Links
Entry 1 of 398
Last Page | Next Page
4/24/2008
-
BioAlliance Pharma Announces Preliminary Results From The Pivotal US Phase III Trial For Loramyc(TM)
|
BioAlliance Pharma SA (Paris:BIO) a field pharmaceutic company focused on the care of opportunistic infections, in cancer and HIV, announced the preliminary positive results for its US pivotal Phase III clinical trial with Loramyc? (miconazole Lauriad®), Mucoadhesive Buccal Tablets (MBT) full-blown for the rehabilitation of OroPharyngeal Candidiasis in immunocompromised population. More: - Continued here |
Post A Comment! :: Send to a Friend! |
Share and enjoy
